Promega Corporation launched a series of ATP assay kits with increased luminescent stability designed to support high-throughput screening with the aim of drug discovery. .In September 2023 ...
The NULISAqpcr Custom Assay Development Kit provides unmatched flexibility, enabling scientists to utilize their own antibodies to develop targeted assays with exceptional sensitivity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback